Patents by Inventor Knut E.A. Lundin

Knut E.A. Lundin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD OF DIAGNOSING CELIAC DISEASE
    Publication number: 20210010077
    Abstract: The present invention relates to a method for diagnosing celiac disease in a subject, or monitoring a subjects response to treatment for celiac disease. The method comprises analysing the subjects TCR repertoire for the presence of gluten-specific TCR sequences, determining a normalised score for the frequency of the gluten-specific TCR sequences in the subjects TCR repertoire and comparing the normalised score to a pre-determined disease threshold.
    Type: Application
    Filed: March 25, 2019
    Publication date: January 14, 2021
    Inventors: Ludvig M. SOLLID, Shuo-Wang QIAO, Ralf Stefan NEUMANN, Geir Kjetil SANDVE, Louise Fremgaard RISNES, Asbjørn CHRISTOPHERSEN, Shiva DAHAL-KOIRALA, Knut E. A. LUNDIN
  • Detection of gluten-specific t-cells
    Patent number: 10677794
    Abstract: The present invention relates to compositions and methods for visualizing disease-specific T-cells. In particular, the present invention relates to compositions and methods for use in the diagnosis, monitoring of progression, monitoring of response to therapy, and selection of patients for therapy of autoimmune diseases characterized by selective expansion of disease-specific effector memory T-cells.
    Type: Grant
    Filed: May 14, 2014
    Date of Patent: June 9, 2020
    Assignee: OSLO UNIVERSITETSSYKEHUS HF
    Inventors: Ludvig Sollid, Shuo-wang Qiao, Asbjorn Christophersen, Knut E. A. Lundin
  • DETECTION OF GLUTEN-SPECIFIC T-CELLS
    Publication number: 20160109443
    Abstract: The present invention relates to compositions and methods for visualizing disease-specific T-cells. In particular, the present invention relates to compositions and methods for use in the diagnosis, monitoring of progression, monitoring of response to therapy, and selection of patients for therapy of autoimmune diseases characterized by selective expansion of disease-specific effector memory T-cells.
    Type: Application
    Filed: May 14, 2014
    Publication date: April 21, 2016
    Inventors: Ludvig Sollid, Shuo-wang Qiao, Asbjorn Christophersen, Knut E.A. Lundin